The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 12, 2024
Filed:
Mar. 14, 2019
Applicant:
Biond Biologics Ltd., Misgav, IL;
Inventors:
Motti Hakim, Kibbutz Gazit, IL;
Dror Alishekevitz, Kiryat Tivon, IL;
Dana Haves Ziv, Karmiel, IL;
Edna Meilin, Kfar Veradim, IL;
Yair Sapir, Manof, IL;
Avidor Shulman, Rakefet, IL;
Tehila Ben-Moshe, Tel Aviv, IL;
Ilana Mandel, Manof, IL;
Assignee:
BIOND BIOLOGICS LTD., Misgav, IL;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); C07K 16/28 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); G01N 33/57488 (2013.01); A61K 45/06 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/622 (2013.01); G01N 2333/70521 (2013.01); G01N 2500/04 (2013.01);
Abstract
Methods of treating cancer and improving immunotherapies comprising decreasing soluble immune receptor levels are provided. Agents that bind membranal immune receptor and inhibit proteolytic cleavage of the receptor and agents that bind soluble immune receptor and that are neither receptor agonists nor antagonists are also provided, as are methods of producing these agents.